A Comparative Approach To The Regulation Of Human Embryonic Stem Cell Research In Europe

Kopaonik school of natural law perception of dignity and legal discourse in Europe

“…This approach, which reflects the KPD, is not adopted by any European state. 120 The second re-gimes accept a middle way approach, "introducing gradualist approach", whereby the protection afforded to the embryo is dependent upon its stage of development. 121 Accordingly, the spectrum of national legislation in Europe encompasses a regulation which permits embryo research and their creation for such purposes as well as the procurement of human embryonic stem cells from supernumerary embryos in certain circumstances; 122 it also prohibits the procurement of human embryonic stem cells from any embryos including supernumerary or otherwise.…”

Recordkeeping research tools in a multi-disciplinary context for cross-jurisdictional health records systems

“…All these records needed to be reliable and authentic for their own purposes. Therefore, the research needed to address which data stores contained records to be regarded as primary, original, complete and authentic (Iacovino 2004a).…”

“…Of course, the political complexity of multiple jurisdictions and the lack of clear articulation of governance for the HealthConnect system impede development of this clarity; however, reliability and authenticity, and consequently trust in the system will be severely compromised without it. The notion of trusted third parties who could store distributed records was not addressed (Iacovino 2004a). …”

An international comparative legal analysis of the regulation of research with human embryonic stem cells

“…Die Regelungen zur grundsätzlichen Möglichkeit der (fremdnützigen) Forschung mit In-vitro-Embryonen reichen vom ausnahmslosen Verbot (Deutschland, Frankreich (bis 2004) [28], Irland [29] [29]), sei es im Sinne einer an gewisse, näher bestimmte Voraussetzungen geknüpften Zulässigkeit (z. B. Belgien, China, England, Japan, Massachusetts/USA).…”